Literature DB >> 12788938

Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions.

Josema Torres1, Joe Rodriguez, Michael P Myers, Miguel Valiente, Jonathan D Graves, Nicholas K Tonks, Rafael Pulido.   

Abstract

PTEN phosphatase is one of the most commonly targeted tumor suppressors in human cancers and a key regulator of cell growth and apoptosis. We have found that PTEN is cleaved by caspase-3 at several target sites, located in unstructured regions within the C terminus of the molecule. Cleavage of PTEN was increased upon TNFalpha-cell treatment and was negatively regulated by phosphorylation of the C-terminal tail of PTEN by the protein kinase CK2. The proteolytic PTEN fragments displayed reduced protein stability, and their capability to interact with the PTEN interacting scaffolding protein S-SCAM/MAGI-2 was lost. Interestingly, S-SCAM/MAGI-2 was also cleaved by caspase-3. Our findings suggest the existence of a regulatory mechanism of protein stability and PTEN-protein interactions during apoptosis, executed by caspase-3 in a PTEN phosphorylation-regulated manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788938     DOI: 10.1074/jbc.M212610200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation.

Authors:  Alexias Safi; Marie Vandromme; Sabine Caussanel; Laure Valdacci; Dominique Baas; Marc Vidal; Gilbert Brun; Laurent Schaeffer; Evelyne Goillot
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 3.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

4.  Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs.

Authors:  Anabel Gil; Amparo Andrés-Pons; Elena Fernández; Miguel Valiente; Josema Torres; Javier Cervera; Rafael Pulido
Journal:  Mol Biol Cell       Date:  2006-06-28       Impact factor: 4.138

Review 5.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

6.  p85 Associates with unphosphorylated PTEN and the PTEN-associated complex.

Authors:  Rosalia Rabinovsky; Panisa Pochanard; Chontelle McNear; Saskia M Brachmann; Jonathan S Duke-Cohan; Levi A Garraway; William R Sellers
Journal:  Mol Cell Biol       Date:  2009-07-27       Impact factor: 4.272

7.  Regulation of caspase pathways by protein kinase CK2: identification of proteins with overlapping CK2 and caspase consensus motifs.

Authors:  Jacob P Turowec; James S Duncan; Greg B Gloor; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

Review 8.  Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Authors:  Nicholas K Tonks
Journal:  FEBS J       Date:  2013-01-17       Impact factor: 5.542

9.  The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization.

Authors:  Fatemeh Fouladkou; Tamara Landry; Hiroshi Kawabe; Antje Neeb; Chen Lu; Nils Brose; Vuk Stambolic; Daniela Rotin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

10.  UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes.

Authors:  M Ming; W Han; J Maddox; K Soltani; C R Shea; D M Freeman; Y-Y He
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.